" " indicates required fields
The partnership will leverage EVSec platform with HARMAN’s Automotive Engineering Services capabilities to automate compliance and regulatory monitoring with US DoC 791D Rule Jerusalem, Israel,
The new capability is designed to give organizations the tools and automation they need to meet regulatory requirements quickly, confidently, and without slowing innovation Jerusalem,
What is an SBOM and why is it Important? A Software Bill of Materials (SBOM) is a foundational cybersecurity and compliance artifact that provides a
Why The New FDA Update Matters Right Now for MDMs The FDA’s Final Cybersecurity Guidance of June 2025 introduces significant new requirements under the FD&C
Introduction The EU’s Network and Information Systems Directive 2 (NIS2, Directive (EU) 2022/2555) came into effect in late 2024, establishing a new benchmark for cybersecurity
[Read the Chinese version of this announcement] Tel Aviv, Israel and Shanghai, China – July 30, 2025: C2A Security, the only context-driven product security orchestration
[Read the English version of this announcement] 艾体宝正式宣布与全球领先的网络安全合规平台提供商C2A Security达成战略合作。双方将整合国际领先技术与本土化服务能力，为能源、制造、交通、智能终端及关键基础设施等行业提供覆盖产品全生命周期的安全合规解决方案，助力企业高效应对GB 44495-2024、ISO/SAE 21434等国内外法规要求，加速数字化转型与全球化布局。 C2A Security同时宣布，Eason Yu正式加入公司并出任中国大陆地区客户管理负责人，常驻上海。Eason 曾在Cybellum、HARMAN等企业担任要职，在网络安全领域拥有丰富经验。他的加入，将进一步提升C2A Security在中国市场的本地化服务能力，为客户提供更高效、更精准的合规支持。 关于C2A Security C2A Security成立于2016年，总部位于以色列，是网络安全自动化与风险管理领域的创新领导者，专注于为关键行业提供可持续的网络安全治理方案。团队80%为技术专家，拥有70+项技术专利及CES创新奖(CES Innovation Awards）、欧洲移动创新奖（CLEPA Innovation Awards）等多项国际荣誉。 其核心产品EVSec平台作为业内领先的”整体性安全合规平台”，是集威胁建模、合规评估、风险监测、报告自动化于一体的全生命周期网络安全管理平台。目前，该平台已为戴姆勒卡车、医科达、安波福、宝马集团、NTT
In early 2025, security researchers uncovered a critical vulnerability in the Contec CMS8000 patient monitor system – an affordable, widely deployed device in hospitals and
Medcrypt’s Guardian PKI and Cryptography Platform integrates into C2A Security’s Product Security Orchestration Platform to provide end-to-end product security and compliance to medical device manufacturers
